probiotics

Sequential and Johnson & Johnson enter partnership to develop new genomic-based skin test

Oliver Worsley: ‘The collaboration will give us the opportunity to further understand how molecular changes on the skin may translate to skin and human health’.

Stress management during the COVID-19 pandemic: new trial finds probiotics to benefit the quality of sleep and mood

New study shows that specific probiotics significantly contribute to the modulation of mood and sleep quality during stressful periods.

TargEDys: the potential of LpWJL as a potent probiotic supporting juvenile growth

New study shows that these probiotic properties are strain-specific and involve NOD2 signaling. Components of its cell wall could be novel postbiotics.

Sacco System launches Microbiome, the complete suite to support companies worldwide

Marco Caspani: ‘With the launch of our new Microbial Therapeutic business-line we are directing our efforts and strong focus to the field of Biotherapeutics’.

Holobiome and Johnson & Johnson enter partnership to develop next-generation probiotics for infant and maternal health

Microbiome platform company Holobiome announces collaboration to support infant and maternal immune health.

Clinically tested probiotics for stress management designed by SynBalance

A new scientific publication on the beneficial effect of probiotics on mood and sleep in healthy adults facing daily stress situation during COVID-19 pandemic.

Chr. Hansen HMOs get Novel Food approval in EU  

Final EU authorization of LNT, 3-FL and 3’-SL for safe use in infant formula at the highest dosage levels

IPA expands scope to include prebiotics, postbiotics and synbiotics

The International Probiotics Association’s expansion is part of the organization’s strategy to help the ’biotics’ industry grow in response to market demands.

Ferring Pharmaceuticals announces availability of REBYOTA™ by prescription in the United States

Rebyota is the first and only FDA-approved Microbiome-Based Treatment for the prevention of recurrence of C. diff infection in adults.

ADM expands probiotics and postbiotic production with Spain facility

Chicago-based company said it invested more than $30 million to help meet rising global demand

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top